We’re happy to announce the lab will join nine other labs in the Collaboration to Infer Regulatory Circuits and to Uncover Innovative Therapeutic Strategies (CIRCUITS), a new initiative to translate genetic findings into therapies for Alzheimer’s disease. We’ll be combining computational and experimental techniques to study how genetic variation in enhancer regions influences Alzheimer’s disease predisposition. The award tops off the lab’s first year, and kicks off an exciting start to the new one.